Andrew Hack

Insider Reports History

Entity
Individual
Location
300 Third Street, First Floor, Cambridge, MA
Signature
/s/ Andrew Hack
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Hack:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. Director Class A Common Stock 2.7M $222M $82.33 Jun 12, 2024 Indirect
DYNAVAX TECHNOLOGIES CORP Director Common Stock 915K $13.7M $15.00 Aug 8, 2023 Indirect
Nuvalent, Inc. Director Class A Common Stock 2.5K $206K $82.33 Jun 12, 2024 Direct
DYNAVAX TECHNOLOGIES CORP Director Common Stock 10.7K $161K $15.00 Aug 8, 2023 Direct
Mersana Therapeutics, Inc. Director Stock Option (right to buy) 55K Jun 11, 2024 Direct
Nuvalent, Inc. Director Stock Option (right to buy) 3.79K Jun 12, 2024 Direct

Insider Reports Filed by Andrew Hack

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NUVL Nuvalent, Inc. Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
MRSN Mersana Therapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 12, 2024 Director
NUVL Nuvalent, Inc. Mar 27, 2024 2 -$64M 4 Mar 29, 2024 Director
DVAX DYNAVAX TECHNOLOGIES CORP Aug 8, 2023 1 -$21.6M 4 Aug 10, 2023 Director
NUVL Nuvalent, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
DVAX DYNAVAX TECHNOLOGIES CORP Jun 14, 2023 1 -$6.34M 4 Jun 16, 2023 Director
MRSN Mersana Therapeutics, Inc. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 26, 2023 2 $0 4 May 31, 2023 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 18, 2023 1 -$10.6M 4 May 19, 2023 Director
DVAX DYNAVAX TECHNOLOGIES CORP Dec 6, 2022 1 -$17.4M 4 Dec 8, 2022 Director
NUVL Nuvalent, Inc. Nov 3, 2022 1 $5M 4 Nov 3, 2022 Director
DVAX DYNAVAX TECHNOLOGIES CORP Aug 15, 2022 1 -$44M 4 Aug 17, 2022 Director
NUVL Nuvalent, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
MRSN Mersana Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
MRSN Mersana Therapeutics, Inc. May 31, 2022 2 $312K 4 Jun 2, 2022 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 26, 2022 2 $0 4 May 27, 2022 Director
MRSN Mersana Therapeutics, Inc. May 24, 2022 3 $854K 4 May 26, 2022 Director
MRSN Mersana Therapeutics, Inc. May 19, 2022 3 $746K 4 May 23, 2022 Director
MRSN Mersana Therapeutics, Inc. May 16, 2022 3 $1.14M 4 May 18, 2022 Director
MRSN Mersana Therapeutics, Inc. Apr 13, 2022 1 $2.5M 4 Apr 14, 2022 Director
MRSN Mersana Therapeutics, Inc. Apr 12, 2022 1 $2.5M 4 Apr 13, 2022 Director
MRSN Mersana Therapeutics, Inc. Feb 7, 2022 1 $5.02M 4 Feb 8, 2022 Director
MRSN Mersana Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
MRSN Mersana Therapeutics, Inc. Dec 30, 2021 1 $5.01M 4 Jan 4, 2022 Director
MRSN Mersana Therapeutics, Inc. Dec 29, 2021 1 $5.03M 4 Jan 3, 2022 Director
DVAX DYNAVAX TECHNOLOGIES CORP Aug 27, 2021 3 -$32.4M 4 Aug 27, 2021 Director
DVAX DYNAVAX TECHNOLOGIES CORP Aug 9, 2021 3 -$24.3M 4 Aug 11, 2021 Director
NUVL Nuvalent, Inc. Aug 2, 2021 3 $12.5M 4 Aug 4, 2021 Director
NUVL Nuvalent, Inc. Jul 28, 2021 1 $0 4 Jul 30, 2021 Director
NUVL Nuvalent, Inc. Jul 28, 2021 0 $0 3 Jul 28, 2021 Director
MRSN Mersana Therapeutics, Inc. Jun 11, 2021 1 $0 4 Jun 15, 2021 Director
DVAX DYNAVAX TECHNOLOGIES CORP Jun 10, 2021 1 $0 4 Jun 11, 2021 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 28, 2021 1 $0 4 Jun 2, 2021 Director